Newsroom

Sorted by: Latest

-

CTP N.V. Q1-2026 Results

AMSTERDAM--(BUSINESS WIRE)--Regulatory News: CTP N.V. (CTPNV.AS), (“CTP”, the “Group” or the “Company”) recorded in Q1-2026 Gross Rental Income of €205.1 million, up 12.3% y-o-y with like-for-like rental growth of 4.6% - an accelerated growth rate versus FY-2025 and primarily driven by indexation and reversion on renegotiations and expiring leases. As at 31 March 2026, the annualised rental income increased to €849.3 million. Together with potential rental income of €154 million coming from 2.0...
-

X-FAB First Quarter 2026 Results

TESSENDERLO-HAM, Belgium--(BUSINESS WIRE)--Regulatory News: X-FAB Silicon Foundries SE (BOURSE:XFAB): Highlights Q1 2026: Revenue was USD 195.6 million, down 4% year-on-year (YoY) and down 12% quarter-on-quarter (QoQ) Excluding the impact from revenue recognized over time (IFRS 15), revenue was USD 205.8 million, above the guided range of USD 190-200 million. Microsystems business with an all-time high revenue at USD 33.7 million, up 42% YoY and up 35% QoQ Strong growth of wide-bandgap revenue...
-

Résultats X-FAB du premier trimestre 2026

TESSENDERLO-HAM, Belgique--(BUSINESS WIRE)--Regulatory News: X-FAB Silicon Foundries SE (BOURSE:XFAB): Faits Marquants relatifs au premier trimestre 2026 : Chiffre d’affaires trimestriel de 195,6 millions USD, en recul de 4 % par rapport au 1er trimestre 2025 et de 12 % par rapport au 4ème trimestre 2025. En excluant l’impact des revenus constatés à l’avancement, conformément aux normes IFRS 15, le chiffre d’affaires du 1er trimestre aurait été de 205,8 millions USD, se situant bien au-delà de...
-

Genentech to Present Extensive Data Showcasing Its Industry-Leading Ophthalmology Portfolio at ARVO 2026

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that it will showcase key real-world, product and pipeline data from its ophthalmology portfolio at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, held May 3-7 in Denver. The data being presented emphasize Genentech’s focus on preserving vision through innovative therapies, including Vabysmo® (faricimab-svoa), Susvimo® (ranibizumab i...
-

CUPE BC Convenes Annual Convention in Victoria

VICTORIA, British Columbia--(BUSINESS WIRE)--B.C.’s largest union is setting its course to defend crucial public services and the rights of workers that deliver them. CUPE BC, the provincial division of the Canadian Union of Public Employees, kicked off its annual convention this evening in Victoria with over 500 union members and guests from across the province. Karen Ranalletta, president of CUPE BC, set the tone for the 4-day convention by highlighting how CUPE members in the province have d...
-

Samenvatting: OpenGate Capital ondertekent een definitief akkoord om de afdeling Europa en Midden-Oosten van Total Safety over te nemen

NEW YORK & PARIJS--(BUSINESS WIRE)--OpenGate Capital (“OpenGate”), een internationale participatiemaatschappij, maakte vandaag bekend dat het een definitief akkoord heeft ondertekend om de EMEA-afdeling (Europa en het Midden-Oosten) over te nemen van Total Safety, een portfoliobedrijf van Littlejohn & Co.. Total Safety EMEA is een toonaangevende leverancier van missiekritieke oplossingen voor veiligheid en naleving ten dienste van petrochemie- en olie & gasklanten in EMEA. Het bedrijf r...
-

Veradermics Announces Pricing of Upsized Public Offering and Private Placement

NEW HAVEN, Conn.--(BUSINESS WIRE)--Veradermics, Incorporated (“Veradermics”) (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced the pricing of its upsized public offering of 3,843,790 shares of its common stock at a public offering price of $100.00 per share. All of the shares are being offered by Veradermics. The gross proceeds from the offering, before deducting underwriting...
-

Riassunto: OpenGate Capital firma un accordo definitivo per acquisire la divisione Europa e Medio Oriente di Total Safety

NEW YORK e PARIGI--(BUSINESS WIRE)--OpenGate Capital (“OpenGate”), società globale di private equity, ha annunciato oggi di aver firmato un accordo definitivo per l'acquisizione della divisione Europa e Medio Oriente (“EMEA”) di Total Safety, una società del portafoglio Littlejohn & Co. Total Safety EMEA è uno dei principali fornitori di soluzioni di sicurezza e conformità di importanza critica al servizio di clienti nel settore petrolchimico e del gas in tutta la regione EMEA. La società è...
-

OpenGate Capital signe un accord définitif en vue de l’acquisition de la division Europe et Moyen-Orient de Total Safety

NEW YORK et PARIS--(BUSINESS WIRE)--OpenGate Capital (« OpenGate »), une société mondiale de capital-investissement, a annoncé aujourd’hui avoir signé un accord définitif en vue de l’acquisition de la division Europe et Moyen-Orient (« EMEA ») de Total Safety, une société du portefeuille de Littlejohn & Co. Total Safety EMEA est l’un des principaux fournisseurs de solutions de sécurité et de conformité essentielles à la mission, au service de clients des secteurs pétrochimique, pétrolier et...
-

OpenGate Capital schließt verbindliche Vereinbarung zur Übernahme der Europa- und Nahost-Sparte von Total Safety ab

NEW YORK und PARIS--(BUSINESS WIRE)--OpenGate Capital („OpenGate“), ein weltweit tätiges Private-Equity-Unternehmen, gab heute bekannt, dass es eine verbindliche Vereinbarung zur Übernahme der Europa- und Nahost-Sparte („EMEA“) von Total Safety, einem Portfoliounternehmen von Littlejohn & Co., abgeschlossen hat. Total Safety EMEA ist ein führender Anbieter von geschäftskritischen Sicherheits- und Compliance-Lösungen für Kunden in der Petrochemie sowie der Öl- und Gasindustrie in der EMEA-Re...